During a recent OncLive Peer Exchange, panelists discussed testing strategies, updated data, and treatment sequencing in ROS1+ NSCLC.

Aaron Gerds, MD, MS, and Anthony M. Hunter, MD, break down the challenges of anemia management in myelofibrosis and potential treatment avenues.

Kevin Kalinsky, MD, MS, FASCO, discusses the role of integrative oncology programs and the importance of survivorship clinics within cancer care.

A record number of Emory faculty have been elected to the newest class of AAAS Fellows in recognition of outstanding efforts to advance science.

New research led by an Emory oncologist links obesity to rising cancers in young adults and shows that losing 10% of body weight could make a difference.

Artificial intelligence can quantify calcification build-up in breast arteries, which is strongly linked to the risk of heart attack, stroke, and death

Kevin Kalinsky, MD, MS, FASCO, notes insights from a molecular tumor board discussion about the optimal management of HR-positive metastatic breast cancer.

Mehmet Bilen, MD, discusses findings from a real-world analysis of apalutamide vs darolutamide in mCSPC.

Faculty, clinicians and fellows from Winship Cancer Institute of Emory University will lead sessions and present important new findings at the 48th San Antonio Breast Cancer Symposium (SABCS) in San A...

Timothy Gershon, MD, PhD, discusses how the FDA approval of mirdametinib will affect the treatment paradigm for adult patients with NF1-associated PNs.

Melanoma is a serious and often deadly type of skin cancer. Although immunotherapy has saved many lives, it still doesn’t work for every patient. Our lab is developing ways to give the immune system a...